Identification of key genes and specific pathways potentially involved in androgen-independent, mitoxantrone-resistant prostate cancer

References

• KamangarFDoresGMAndersonWFPatterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the worldJ Clin Oncol200624142137215016682732
   PubMed Web of Science ®Google Scholar
• RydzewskaLHMBurdettSValeCLAdding abiraterone to androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer: a systematic review and meta-analysisEur J Cancer2017848810128800492
   PubMed Web of Science ®Google Scholar
• LiYLiCXYeHDecrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasionJ Cell Mol Med2008126B2790279818266956
   PubMed Web of Science ®Google Scholar
• NairRVSanthakumarHJayasreeRSGold nanorods decorated with a cancer drug for multimodal imaging and therapyFaraday Discuss201820742343529355869
   PubMed Web of Science ®Google Scholar
• WangAYWeinerHGreenMA phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemiaJ Hematol Oncol2018111429304833
   PubMed Web of Science ®Google Scholar
• Aguirre-HernándezCMaya-PinedaHMillánJSSensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus Ad∆∆ through Bcl-2-dependent attenuation of autophagyOncogenesis201871629362360
   PubMedGoogle Scholar
• FlaigTWPotluriRCNgYToddMBMehraMTreatment evolution for metastatic castration-resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real-world dataCancer Med20165218219126710718
   PubMed Web of Science ®Google Scholar
• SalernoSda SettimoFTalianiSRecent advances in the development of dual topoisomerase I and II inhibitors as anticancer drugsCurr Med Chem201017354270429020939813
   PubMed Web of Science ®Google Scholar
• Gomez-SarosiLSunYColemanIBianchi-FriasDNelsonPSDNA Damage Induces a Secretory Program in the Quiescent TME That Fosters Adverse Cancer PhenotypesMol Cancer Res201715784285128356331
   PubMed Web of Science ®Google Scholar
• CollierACGanleyNATingleMDUDP-glucuronosyltransferase activity, expression and cellular localization in human placenta at termBiochem Pharmacol200263340941911853692
   PubMed Web of Science ®Google Scholar
• HuDGMackenziePIMckinnonRAMeechRGenetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer riskDrug Metab Rev2016481476926828111
   PubMed Web of Science ®Google Scholar
• GuoXZhangCGuoQThe homogeneous and heterogeneous risk factors for the morbidity and prognosis of bone metastasis in patients with prostate cancerCancer Manag Res2018101639164629970963
   PubMed Web of Science ®Google Scholar
• JamiesonNBMakerAVGene-expression profiling to predict responsiveness to immunotherapyCancer Gene Ther201724313414027834354
   PubMed Web of Science ®Google Scholar
• SzukiewiczDKochanowskiJMittalTKPyzlakMSzewczykGCendrowskiKCX3CL1 (fractalkine) and TNFα production by perfused human placental lobules under normoxic and hypoxic conditions in vitro: the importance of CX3CR1 signalingInflamm Res201463317918924270813
   PubMed Web of Science ®Google Scholar
• ParkMHLeeJSYoonJHHigh expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinomaJ Surg Oncol2012106438639222422195
   PubMed Web of Science ®Google Scholar
• BorsigLWolfMJRoblekMLorentzenAHeikenwalderMInflammatory chemokines and metastasis-tracing the accessoryOncogene201433253217322423851506
   PubMed Web of Science ®Google Scholar
• ZhangWThompsonBJHietakangasVCohenSMMAPK/ERK signaling regulates insulin sensitivity to control glucose metabolism in DrosophilaPLoS Genet2011712e100242922242005
   PubMed Web of Science ®Google Scholar
• GoldshmitYSpanevelloMDTajouriSEphA4 blockers promote axonal regeneration and functional recovery following spinal cord injury in micePLoS One201169e2463621931787
   PubMed Web of Science ®Google Scholar
• HusaAMMagićŽLarssonMFornanderTPérez-TenorioGEPH/ephrin profile and EPHB2 expression predicts patient survival in breast cancerOncotarget2016716213622218026870995
   PubMedGoogle Scholar
• OshimaTAkaikeMYoshiharaKOverexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancerInt J Oncol200833357357718695888
   PubMed Web of Science ®Google Scholar
• KowalskiPSteinUSchefferGLLageHModulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2Cancer Gene Ther20029757958612082458
   PubMed Web of Science ®Google Scholar
• GangavarapuKJAzabdaftariGMorrisonCDAldehyde dehydrogenase and ATP binding cassette transporter G2 (ABCG2) functional assays isolate different populations of prostate stem cells where ABCG2 function selects for cells with increased stem cell activityStem Cell Res Ther20134513224405526
   PubMedGoogle Scholar
• RicciJWLovatoDMSevernsVSklarLALarsonRSNovel ABCG2 Antagonists Reverse Topotecan-Mediated Chemotherapeutic Resistance in Ovarian Carcinoma XenograftsMol Cancer Ther201615122853286227671528
   PubMed Web of Science ®Google Scholar
• SobekKMCummingsJLBacichDJO’KeefeDSContrasting roles of the ABCG2 Q141K variant in prostate cancerExp Cell Res20173541404728300564
   PubMed Web of Science ®Google Scholar
• BauerfeldCPRastogiRPirockinaiteGTLR4-mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophagesJ Immunol201218862847285722312125
   PubMed Web of Science ®Google Scholar
• MillerVLLinHKMuruganPAldo-keto reductase family 1 member C3 (AKR1C3) is expressed in adenocarcinoma and squamous cell carcinoma but not small cell carcinomaInt J Clin Exp Pathol20125427828922670171
   PubMed Web of Science ®Google Scholar
• O’ReillyMWKempegowdaPWalshMAKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women with Polycystic Ovary SyndromeJ Clin Endocrinol Metab201710293327333928645211
   PubMed Web of Science ®Google Scholar
• DaviesNJHaydenRESimpsonPJAKR1C isoforms represent a novel cellular target for jasmonates alongside their mitochondrial-mediated effectsCancer Res200969114769477519487289
   PubMed Web of Science ®Google Scholar
• KarunasingheNMastersJFlanaganJUFergusonLRInfluence of Aldo-keto Reductase 1C3 in Prostate Cancer – A Mini ReviewCurr Cancer Drug Targets201717760361628359237
   PubMed Web of Science ®Google Scholar
• KnuuttilaMYatkinEKallioJCastration induces up-regulation of intratumoral androgen biosynthesis and androgen receptor expression in an orthotopic VCaP human prostate cancer xenograft modelAm J Pathol201418482163217324949550
   PubMed Web of Science ®Google Scholar
• FankhauserMTanYMacintyreGCanonical androstenedione reduction is the predominant source of signaling androgens in hormone-refractory prostate cancerClin Cancer Res201420215547555724771644
   PubMed Web of Science ®Google Scholar
• BrasierARThe NF-kappaB regulatory networkCardiovasc Toxicol20066211113017303919
   PubMed Web of Science ®Google Scholar
• BakhoumSFNgoBLaughneyAMChromosomal instability drives metastasis through a cytosolic DNA responseNature2018553768946747229342134
   PubMed Web of Science ®Google Scholar
• ParkSHChoJYOhSWArctigenin protects against ultraviolet-A-induced damage to stemness through inhibition of the NF-κB/MAPK pathwayChem Biol Interact2018282636829317250
   PubMed Web of Science ®Google Scholar
• MaJSunXGuoTInterleukin-1 receptor antagonist inhibits angiogenesis via blockage IL-1α/PI3K/NF-κβ pathway in human colon cancer cellCancer Manag Res2017948149329062241
   PubMed Web of Science ®Google Scholar
• LinGLiCHuangCCo-expression of NF-κB-p65 and phosphorylated NF-κB-p105 is associated with poor prognosis in surgically resectable non-small cell lung cancerJ Cell Mol Med20182231923193029363879
   PubMed Web of Science ®Google Scholar
• ShenXGWangCLiYDownregulation of caspase-10 predicting poor survival after resection of stage II colorectal cancerInt J Colorectal Dis201126121519152421559821
   PubMed Web of Science ®Google Scholar
• DwivediPPAndersonPHTilleyWDMayBKMorrisHARole of oncoprotein growth factor independent-1 (GFI1) in repression of 25-hydroxyvitamin D 1alpha-hydroxylase (CYP27B1): a comparative analysis in human prostate cancer and kidney cellsJ Steroid Biochem Mol Biol20071033–574274617207994
   PubMed Web of Science ®Google Scholar
• SatterwhiteESonokiTWillisTGThe BCL11 gene family: involvement of BCL11A in lymphoid malignanciesBlood200198123413342011719382
   PubMed Web of Science ®Google Scholar
• YinJZhangFTaoHBCL11A expression in acute phase chronic myeloid leukemiaLeuk Res201647889227285855
   PubMed Web of Science ®Google Scholar
• JiangBYZhangXCSuJBCL11A overexpression predicts survival and relapse in non-small cell lung cancer and is modulated by microRNA-30a and gene amplificationMol Cancer2013126123758992
   PubMed Web of Science ®Google Scholar
• KhaledWTChoon LeeSStinglJBCL11A is a triple-negative breast cancer gene with critical functions in stem and progenitor cellsNat Commun20156598725574598
   PubMed Web of Science ®Google Scholar
• ZhangNJiangBYZhangXCThe BCL11A-XL expression predicts relapse in squamous cell carcinoma and large cell carcinomaJ Thorac Dis2015791630163626543611
   PubMed Web of Science ®Google Scholar
• Santuario-FacioSKCardona-HuertaSPerez-ParamoYXA New Gene Expression Signature for Triple Negative Breast Cancer Using Frozen Fresh Tissue before Neoadjuvant ChemotherapyMol Med201723128097289
   PubMed Web of Science ®Google Scholar
• Jamal-HanjaniMWilsonGAMcgranahanNTracking the Evolution of Non-Small-Cell Lung CancerN Engl J Med2017376222109212128445112
   PubMed Web of Science ®Google Scholar